- Home
- Publications
- Publication Search
- Publication Details
Title
The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 4, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-11-06
DOI
10.3389/fonc.2014.00252
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Akt Signaling Leads to Stem Cell Activation and Promotes Tumor Development in Epidermis
- (2014) Carmen Segrelles et al. STEM CELLS
- Selective Requirement of PI3K/PDK1 Signaling for Kras Oncogene-Driven Pancreatic Cell Plasticity and Cancer
- (2013) Stefan Eser et al. CANCER CELL
- PIK3CAgene alterations in bladder cancer are frequent and associate with reduced recurrence in non-muscle invasive tumors
- (2013) Marta Dueñas et al. MOLECULAR CARCINOGENESIS
- Genetically engineered mouse models of PI3K signaling in breast cancer
- (2013) Sjoerd Klarenbeek et al. Molecular Oncology
- Conditional Transgenic Expression of PIM1 Kinase in Prostate Induces Inflammation-Dependent Neoplasia
- (2013) Maja Narlik-Grassow et al. PLoS One
- Expression of PIK3CA mutant E545K in the mammary gland induces heterogeneous tumors but is less potent than mutant H1047R
- (2013) D S Meyer et al. Oncogenesis
- The essential role of PIM kinases in sarcoma growth and bone invasion
- (2012) M. Narlik-Grassow et al. CARCINOGENESIS
- Telomerase Reactivation following Telomere Dysfunction Yields Murine Prostate Tumors with Bone Metastases
- (2012) Zhihu Ding et al. CELL
- Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis
- (2012) Philip D. Anderson et al. JOURNAL OF CLINICAL INVESTIGATION
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Conditional activation of Pik3ca H1047R in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations
- (2012) W Yuan et al. ONCOGENE
- Physiological Levels of Pik3caH1047R Mutation in the Mouse Mammary Gland Results in Ductal Hyperplasia and Formation of ERα-Positive Tumors
- (2012) Anjali Tikoo et al. PLoS One
- EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours
- (2012) Olga Bornachea et al. Scientific Reports
- A Novel Tumor suppressor network in squamous malignancies
- (2012) Clotilde Costa et al. Scientific Reports
- PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab
- (2011) J. D. Jensen et al. ANNALS OF ONCOLOGY
- Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes
- (2011) Sandrine Boyault et al. BREAST CANCER RESEARCH AND TREATMENT
- Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth
- (2011) David J. Mulholland et al. CANCER CELL
- Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
- (2011) J. R. Adams et al. CANCER RESEARCH
- Luminal Expression of PIK3CA Mutant H1047R in the Mammary Gland Induces Heterogeneous Tumors
- (2011) D. S. Meyer et al. CANCER RESEARCH
- Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis
- (2011) Alyssa L. Kennedy et al. MOLECULAR CELL
- SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
- (2011) Zhihu Ding et al. NATURE
- Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway–dependent and PI3K pathway–independent mechanisms
- (2011) Pixu Liu et al. NATURE MEDICINE
- Hot-spot mutations in p110α of phosphatidylinositol 3-kinase (PI3K): Differential interactions with the regulatory subunit p85 and with RAS
- (2010) Li Zhao et al. CELL CYCLE
- Exploring the Gain of Function Contribution of AKT to Mammary Tumorigenesis in Mouse Models
- (2010) Carmen Blanco-Aparicio et al. PLoS One
- Akt Activation Synergizes with Trp53 Loss in Oral Epithelium to Produce a Novel Mouse Model for Head and Neck Squamous Cell Carcinoma
- (2009) M. Moral et al. CANCER RESEARCH
- Mouse Models to Decipher the PI3K Signaling Network in Human Cancer
- (2009) Oliver Renner et al. CURRENT MOLECULAR MEDICINE
- The PKB/AKT Pathway in Cancer
- (2009) Amancio Carnero CURRENT PHARMACEUTICAL DESIGN
- PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast
- (2009) Hua Li et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality
- (2009) Elena López-Knowles et al. INTERNATIONAL JOURNAL OF CANCER
- PTEN Deficiency in a Luminal ErbB-2 Mouse Model Results in Dramatic Acceleration of Mammary Tumorigenesis and Metastasis
- (2009) Babette Schade et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interactions between Cells with Distinct Mutations in c-MYC and Pten in Prostate Cancer
- (2009) Jongchan Kim et al. PLoS Genetics
- A Prostatic Intraepithelial Neoplasia-Dependent p27Kip1 Checkpoint Induces Senescence and Inhibits Cell Proliferation and Cancer Progression
- (2008) Pradip K. Majumder et al. CANCER CELL
- Activation of Phosphatidylinositol 3-Kinase by Membrane Localization of p110 Predisposes Mammary Glands to Neoplastic Transformation
- (2008) O. Renner et al. CANCER RESEARCH
- Pten Inactivation Accelerates Oncogenic K-ras-Initiated Tumorigenesis in a Mouse Model of Lung Cancer
- (2008) K. Iwanaga et al. CANCER RESEARCH
- Spontaneous Squamous Cell Carcinoma Induced by the Somatic Inactivation of Retinoblastoma and Trp53 Tumor Suppressors
- (2008) A. B. Martinez-Cruz et al. CANCER RESEARCH
- An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer
- (2008) K. Stemke-Hale et al. CANCER RESEARCH
- Conditional Loss of Uterine Pten Unfailingly and Rapidly Induces Endometrial Cancer in Mice
- (2008) T. Daikoku et al. CANCER RESEARCH
- Pten Haploinsufficiency Accelerates Formation of High-Grade Astrocytomas
- (2008) C.-H. Kwon et al. CANCER RESEARCH
- Genetic modelling of the PTEN/AKT pathway in cancer research
- (2008) Oliver Renner et al. Clinical & Translational Oncology
- The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
- (2008) Amancio Carnero et al. CURRENT CANCER DRUG TARGETS
- Angiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration
- (2008) Mariona Graupera et al. NATURE
- Essential roles of PI(3)K–p110β in cell growth, metabolism and tumorigenesis
- (2008) Shidong Jia et al. NATURE
- Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
- (2008) Jeffrey A Engelman et al. NATURE MEDICINE
- The PTEN–PI3K pathway: of feedbacks and cross-talks
- (2008) A Carracedo et al. ONCOGENE
- Class I PI3K in oncogenic cellular transformation
- (2008) L Zhao et al. ONCOGENE
- PI3K pathway alterations in cancer: variations on a theme
- (2008) T L Yuan et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started